FindTrial
Sign In

A prospective phase II study for adjuvant hypofractionated intensity-modulated proton radiotherapy for post operative breast cancer

prospective phase II study for adjuvant hypofractionated intensity-modulated proton radiotherapy for post operative breast cancer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031985
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-04-09
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Case series:proton radiotherapy

Sponsors

Shanghai Pronton and Heavy Ion Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 20-80 years old, post operative breast cancer need radiotherapy, no metastasis pathology conformed

Exclusion criteria

Exclusion criteria: metastasisno pathology, previasly recived radiotherapy

Design outcomes

Primary

MeasureTime frame
heart injury;—

Countries

China

Contacts

Public ContactZhengshan Hong, Qing Zhang
zhengshan.hong@sphic.org.cn+86 13671603629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026